Ophthalmology Times

CONTINUE TO SITE

OR WAIT null SECS

Cataract Surgical Case Study Cataract Therapeutics Glaucoma Insights Branded vs Generics CME Activities Dry Eye Viewpoint Diabetic Eye Disease Viewpoints Diabetic Eye Disease Podcast Dry Eye Concepts Management of Dry Eye Viewpoints Ocular Toxicity in Myeloma WetAMD Viewpoints

Cataract Surgical Case Study Cataract Therapeutics Glaucoma Insights Branded vs Generics CME Activities Dry Eye Viewpoint Diabetic Eye Disease Viewpoints Diabetic Eye Disease Podcast Dry Eye Concepts Management of Dry Eye Viewpoints Ocular Toxicity in Myeloma WetAMD Viewpoints

View More Cataract Clinical Diagnosis Cornea Glaucoma IOL OCT Ocular Allergy Ocular Surface Disease Pediatrics Refractive Retina Technology Therapeutic Cataract & Refractive Understanding Antibiotic Resistance

Cataract Clinical Diagnosis Cornea Glaucoma IOL OCT Ocular Allergy Ocular Surface Disease Pediatrics Refractive Retina Technology Therapeutic Cataract & Refractive Understanding Antibiotic Resistance

All News Blogs COVID-19

Expert Interviews

Medical World News

Expert Interviews Medical World News Podcasts Viewpoints Insights

Health Law & Policy

Personal Finance

Practice Management

Health Law & Policy Money Matters Personal Finance Practice Management

Conference Coverage

Conference Listing

Conference Coverage Conference Listing

Digital Edition

Europe Ophthalmology Times

Supplements and Featured Publications

Digital Edition Europe Ophthalmology Times Modern Retina Supplements and Featured Publications

Partners CME/CE Job Board Sponsored

Print Subscription

eNewsletter Print Subscription

Advertise
Contact Us
Editorial
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2021 MJH Life Sciences and Ophthalmology Times. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Cataract Surgical Case Study
Cataract Therapeutics
Glaucoma Insights
Branded vs Generics
CME Activities
Dry Eye Viewpoint
Diabetic Eye Disease Viewpoints
Diabetic Eye Disease Podcast
Dry Eye Concepts
Management of Dry Eye Viewpoints
Ocular Toxicity in Myeloma
WetAMD Viewpoints

ClinicalSee All >

Cataract
Clinical Diagnosis
Cornea
Glaucoma
IOL
OCT
Ocular Allergy
Ocular Surface Disease
Pediatrics
Refractive
Retina
Technology
Therapeutic Cataract & Refractive
Understanding Antibiotic Resistance

Advertise
Contact Us
Editorial
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2021 MJH Life Sciences^™ and Ophthalmology Times. All rights reserved.

Phase III study eyes intravitreal therapy for exudative AMD

July 1, 2004

Anti-VEGF monoclonal antibody fragment improves vision, reduce fluorescein angiographic leakage

Related Content:

Comparable conscious sedation methods address individual patient needs

Comparable conscious sedation methods address individual patient needs

Investigators uncover health care disparities among US patients

Investigators uncover health care disparities among US patients

Investigators zoom in on future of dry eye treatment

Investigators zoom in on future of dry eye treatment